Strain identifier

BacDive ID: 135661

Type strain: No

Species: Acinetobacter baumannii

Strain history: CIP <- 1970, ATCC <- S.G. Cary <- W.W. Ferguson: strain B5W 72, Bacterium anitratum

NCBI tax ID(s): 470 (species)

« back to strain detail view
For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 8.1 (current version):
version 8:
version 7.1:
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 8.1 (current version)

General

@ref: 34841

BacDive-ID: 135661

keywords: genome sequence, Bacteria, obligate aerobe, mesophilic, Gram-negative

description: Acinetobacter baumannii CIP 70.10 is an obligate aerobe, mesophilic, Gram-negative bacterium of the family Moraxellaceae.

NCBI tax id

  • NCBI tax id: 470
  • Matching level: species

strain history

  • @ref: 34841
  • history: CIP <- 1970, ATCC <- S.G. Cary <- W.W. Ferguson: strain B5W 72, Bacterium anitratum

doi: 10.13145/bacdive135661.20230509.8.1

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/pseudomonadota
  • domain: Bacteria
  • phylum: Pseudomonadota
  • class: Gammaproteobacteria
  • order: Pseudomonadales
  • family: Moraxellaceae
  • genus: Acinetobacter
  • species: Acinetobacter baumannii
  • full scientific name: Acinetobacter baumannii Bouvet and Grimont 1986

@ref: 34841

domain: Bacteria

phylum: Proteobacteria

class: Gammaproteobacteria

order: Pseudomonadales

family: Moraxellaceae

genus: Acinetobacter

species: Acinetobacter baumannii

type strain: no

Morphology

cell morphology

@refgram stainconfidencecell shapemotility
69480negative99.997
34841negativerod-shapedno

colony morphology

  • @ref: 34841

Culture and growth conditions

culture medium

@refnamegrowthcompositionlink
34841MEDIUM 72- for trypto casein soja agaryesDistilled water make up to (1000.000 ml);Trypto casein soy agar (40.000 g)
34841CIP Medium 72yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=72

culture temp

@refgrowthtypetemperaturerange
34841positivegrowth30mesophilic
34841positivegrowth25-45
34841nogrowth10psychrophilic

Physiology and metabolism

oxygen tolerance

  • @ref: 34841
  • oxygen tolerance: obligate aerobe

spore formation

@refspore formationconfidence
69481no100
69480no99.994

halophily

@refsaltgrowthtested relationconcentration
34841NaClpositivegrowth0-4 %
34841NaClnogrowth6 %
34841NaClnogrowth8 %
34841NaClnogrowth10 %

metabolite utilization

@refChebi-IDmetaboliteutilization activitykind of utilization tested
3484116947citrate+carbon source
3484117632nitrate-reduction
3484116301nitrite-reduction
3484117234glucose+/-degradation
3484117632nitrate-respiration

antibiotic resistance

  • @ref: 34841
  • metabolite: 0129 (2,4-Diamino-6,7-di-iso-propylpteridine phosphate)
  • is antibiotic: yes
  • is sensitive: no
  • is resistant: yes

metabolite production

  • @ref: 34841
  • Chebi-ID: 35581
  • metabolite: indole
  • production: no

metabolite tests

@refChebi-IDmetabolitevoges-proskauer-testmethylred-test
3484115688acetoin-
3484117234glucose-

enzymes

@refvalueactivityec
34841oxidase-
34841beta-galactosidase-3.2.1.23
34841alcohol dehydrogenase-1.1.1.1
34841gelatinase-
34841catalase+1.11.1.6
34841gamma-glutamyltransferase-2.3.2.2
34841lysine decarboxylase-4.1.1.18
34841ornithine decarboxylase-4.1.1.17
34841urease+3.5.1.5
68382alkaline phosphatase+3.1.3.1
68382esterase (C 4)+
68382esterase lipase (C 8)+
68382lipase (C 14)-
68382leucine arylamidase+3.4.11.1
68382valine arylamidase-
68382cystine arylamidase-3.4.11.3
68382trypsin-3.4.21.4
68382alpha-chymotrypsin-3.4.21.1
68382acid phosphatase+3.1.3.2
68382naphthol-AS-BI-phosphohydrolase+
68382alpha-galactosidase-3.2.1.22
68382beta-galactosidase+3.2.1.23
68382beta-glucuronidase-3.2.1.31
68382alpha-glucosidase-3.2.1.20
68382beta-glucosidase-3.2.1.21
68382N-acetyl-beta-glucosaminidase-3.2.1.52
68382alpha-mannosidase-3.2.1.24
68382alpha-fucosidase-3.2.1.51

API zym

@refControlAlkaline phosphataseEsteraseEsterase LipaseLipaseLeucine arylamidaseValine arylamidaseCystine arylamidaseTrypsinalpha- ChymotrypsinAcid phosphataseNaphthol-AS-BI-phosphohydrolasealpha- Galactosidasebeta- Galactosidasebeta- Glucuronidasealpha- Glucosidasebeta- GlucosidaseN-acetyl-beta- glucosaminidasealpha- Mannosidasealpha- Fucosidase
34841-+++-+----++-+------

API biotype100

@refGLUFRUGALTREMNESBEMELSACRAFMTEMALLACLTEMbGaMaGaCELGENMbGuESCRIBARAXYLPLERHAFUCMLZDARLLARLXLTDULTAGGLYINOMANMTLTURSORADOHBGLYXERYMDG3MDGSATMUCLTATDTATMTATDMLTLMLTCATETATETTECITGRTGAT2KG5KGTRYNAGGNTPACPATpOBEQATGTEmOBEBATPPATCMTTGEBETPCEABTHINLATCAPCYTHISSUCFUMGREGYTAVTETNTTNGLNITA3OBUAPTGTTPRODALALALASERMNTPROPTYR2KT
34841-------------------+++---------------------+++--++++++------++++++++++++++++++++++------++++++-++++

Safety information

risk assessment

  • @ref: 34841
  • biosafety level: 1
  • biosafety level comment: Risk group (French classification)

Sequence information

Genome sequences

@refdescriptionaccessionassembly leveldatabaseNCBI tax ID
66792Acinetobacter baumannii CIP70.10GCA_001457535completencbi470
66792Acinetobacter baumannii strain CIP70.10470.1738completepatric470
66792Acinetobacter baumannii strain CIP70.10470.4461plasmidpatric470
66792Acinetobacter baumannii CIP 70.102684623147completeimg470

Genome-based predictions

predictions

traitpredictionconfidencetraining_data
spore-formingno100no
flagellatedno94.032no
gram-positiveno97.115no
anaerobicno98.73no
aerobicyes94.817no
halophileno88.139no
spore-formingno96.811no
glucose-utilno61.898no
motileno91.52no
thermophileno99.83yes
glucose-fermentno78.678no

External links

@ref: 34841

culture collection no.: CIP 70.10, ATCC 15151

straininfo link

  • @ref: 92974
  • straininfo: 162

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Enzymology16048925Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii.Heritier C, Poirel L, Lambert T, Nordmann PAntimicrob Agents Chemother10.1128/AAC.49.8.3198-3202.20052005Acinetobacter baumannii/*drug effects/enzymology/genetics, Anti-Bacterial Agents/*metabolism/pharmacology, Carbapenems/*metabolism/pharmacology, Cloning, Molecular, DNA, Bacterial/analysis, Humans, Microbial Sensitivity Tests/standards, Plasmids, Polymerase Chain Reaction, Recombination, Genetic, Transformation, Genetic, *beta-Lactam Resistance, beta-Lactamases/genetics/*metabolismPathogenicity
Pathogenicity20194701Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan.Lin YC, Hsia KC, Chen YC, Sheng WH, Chang SC, Liao MH, Li SYAntimicrob Agents Chemother10.1128/AAC.01398-092010Acinetobacter Infections/*drug therapy, Acinetobacter baumannii/*drug effects/*genetics, Aminoglycosides/pharmacology, Carbapenems/pharmacology, Cephalosporins/pharmacology, DNA Gyrase/genetics, Drug Resistance, Bacterial/*genetics, Drug Resistance, Multiple/*genetics, Fluoroquinolones/pharmacology, Humans, Taiwan, beta-Lactamases/genetics
Genetics26227605Complete Genome Sequence of Acinetobacter baumannii CIP 70.10, a Susceptible Reference Strain for Comparative Genome Analyses.Krahn T, Wibberg D, Maus I, Winkler A, Puhler A, Poirel L, Schluter AGenome Announc10.1128/genomeA.00850-152015
Pathogenicity26953198Intraspecies Transfer of the Chromosomal Acinetobacter baumannii blaNDM-1 Carbapenemase Gene.Krahn T, Wibberg D, Maus I, Winkler A, Bontron S, Sczyrba A, Nordmann P, Puhler A, Poirel L, Schluter AAntimicrob Agents Chemother10.1128/AAC.00124-162016Acinetobacter baumannii/drug effects/*genetics, Bacterial Proteins/genetics, Carbapenems/pharmacology, DNA Transposable Elements/genetics, Gene Transfer, Horizontal/*genetics, Microbial Sensitivity Tests, Plasmids/genetics, beta-Lactamases/genetics
Pathogenicity27216052Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture.Wang YC, Kuo SC, Yang YS, Lee YT, Chiu CH, Chuang MF, Lin JC, Chang FY, Chen TLAntimicrob Agents Chemother10.1128/AAC.00551-162016Acinetobacter Infections/drug therapy, Acinetobacter baumannii/*drug effects, Anti-Bacterial Agents/pharmacology, Biofilms/*drug effects, Carbapenems/pharmacology, Colistin/*pharmacology, Drug Combinations, Drug Resistance, Bacterial, Drug Synergism, Humans, Imipenem/*pharmacology, Meropenem, Microbial Sensitivity Tests/methods, Minocycline/*analogs & derivatives/pharmacology, Sulbactam/*pharmacology, Thienamycins/*pharmacology, Tigecycline
Pathogenicity27436466GES-11-producing Acinetobacter baumannii clinical isolates from Tunisian hospitals: Long-term dissemination of GES-type carbapenemases in North Africa.Chihi H, Bonnin RA, Bourouis A, Mahrouki S, Besbes S, Moussa MB, Belhadj O, Naas TJ Glob Antimicrob Resist10.1016/j.jgar.2016.03.0052016Acinetobacter Infections/microbiology, Acinetobacter baumannii/drug effects/*genetics, Anti-Bacterial Agents, Bacterial Proteins/*genetics, Drug Resistance, Multiple, Bacterial/*genetics, Electrophoresis, Gel, Pulsed-Field, Female, Hospitals, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Tunisia, beta-Lactamases/*geneticsEnzymology
Pathogenicity27543656In vitro activity of SecA inhibitors in combination with carbapenems against carbapenem-hydrolysing class D beta-lactamase-producing Acinetobacter baumannii.Chiu CH, Liu YH, Wang YC, Lee YT, Kuo SC, Chen TL, Lin JC, Wang FDJ Antimicrob Chemother10.1093/jac/dkw3312016Acinetobacter baumannii/*drug effects, Adenosine Triphosphatases/*antagonists & inhibitors, Anti-Bacterial Agents/*pharmacology, Bacterial Proteins/*antagonists & inhibitors, Carbapenems/*pharmacology, *Drug Synergism, Enzyme Inhibitors/*pharmacology, Humans, Microbial Sensitivity Tests, Protein Transport/drug effects, SEC Translocation Channels/*antagonists & inhibitors, SecA Proteins, beta-Lactamases/*metabolismMetabolism
Pathogenicity28663698Efficacy of Mastoparan-AF alone and in combination with clinically used antibiotics on nosocomial multidrug-resistant Acinetobacter baumannii.Lin CH, Lee MC, Tzen JTC, Lee HM, Chang SM, Tu WC, Lin CFSaudi J Biol Sci10.1016/j.sjbs.2016.12.0132016
Enzymology33338207Variability in carbapenemase activity of intrinsic OxaAb (OXA-51-like) beta-lactamase enzymes in Acinetobacter baumannii.Takebayashi Y, Findlay J, Heesom KJ, Warburton PJ, Avison MB, Evans BAJ Antimicrob Chemother10.1093/jac/dkaa5022021*Acinetobacter baumannii/genetics, Anti-Bacterial Agents/pharmacology, *Bacterial Proteins/genetics, Chromatography, Liquid, Drug Resistance, Bacterial, Microbial Sensitivity Tests, Tandem Mass Spectrometry, *beta-Lactamases/geneticsProteome

Reference

@idauthorstitledoi/urlcatalogue
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ10.1099/ijsem.0.004332
34841Curators of the CIPhttps://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%2070.10Collection of Institut Pasteur (CIP 70.10)
66792Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg OvermannAutomatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)https://diaspora-project.de/progress.html#genomes
68382Automatically annotated from API zym
69480Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg OvermannPredictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)https://diaspora-project.de/progress.html#genomes
69481Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. MünchPredictions based on the model GenomeNet Sporulation v. 110.21203/rs.3.rs-2527258/v1
92974Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.StrainInfo: A central database for resolving microbial strain identifiers10.60712/SI-ID162.1